Stocks and Investing Stocks and Investing
Fri, August 14, 2020
Thu, August 13, 2020
Wed, August 12, 2020
Tue, August 11, 2020
Mon, August 10, 2020

Tyler Van Buren Maintained (TBPH) at Buy with Decreased Target to $30 on, Aug 10th, 2020


Published on 2024-10-27 12:00:22 - WOPRAI, Tyler Van Buren
  Print publication without navigation


Tyler Van Buren of Piper Sandler, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Decreased Target from $35 to $30 on, Aug 10th, 2020.

Tyler has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Tyler's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Tyler


  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $29 on, Tuesday, July 7th, 2020
  • Marc Frahm of "Cowen & Co." Initiated at Buy and Held Target at $42 on, Wednesday, May 13th, 2020